Login
$RXRX
$4.05 +$0.25 (6.58%) Close

$RXRX 3 SEC Filings

Filed On Filing
09 Jan 2026 Form 3: Hallett David, CSO

Holds 287,928 shares of Class A Common Stock

19 Mar 2025 Form 3: Bumpus Namandje, Director

No securities owned

19 Mar 2025 Form 3: Sun Elaine D, Director

No securities owned

02 Dec 2024 Form 3: Taylor Ben R, Chief Financial Officer

Holds 61,870 shares of Class A Common Stock

22 Nov 2024 Form 3: Michor Franziska, Director

No securities owned

25 Apr 2024 Form 3: Khan Najat, Director

No securities owned

07 Jun 2023 Form 3: Mauro David J, Chief Medical Officer

Holds 0 shares of No securities are beneficially owned.

20 Apr 2021 Form 3: Mic Capital Partners (PUBLIC) (US) IM, Llc, 10% owner

Holds 1,388,889 shares of Class A Common Stock

15 Apr 2021 Form 3: Mubadala Investment Co Pjsc, 10% owner and 1 other
15 Apr 2021 Form 3: Data Collective IV, L.p., 10% owner and 6 others
15 Apr 2021 Form 3: Bogue Zachary, Director
15 Apr 2021 Form 3: Lux Ventures IV, L.p., 10% owner and 3 others

Holds 12,501 shares of Common Stock

15 Apr 2021 Form 3: Virani Shafique, Chief Corp. Dev. Officer

Holds 18,000 shares of Common Stock

15 Apr 2021 Form 3: Secora Michael, Chief Financial Officer

Holds 379,685 shares of Common Stock

15 Apr 2021 Form 3: Li Dean Y, Director

Holds 582,501 shares of Common Stock

15 Apr 2021 Form 3: Larson Tina Marriott, President and COO

Holds 52,500 shares of Common Stock

15 Apr 2021 Form 3: Hershberg Robert, Director
15 Apr 2021 Form 3: Gibson Christopher, Director

Holds 9,262,500 shares of Common Stock

15 Apr 2021 Form 3: Doyle Ramona, Chief Medical Officer
15 Apr 2021 Form 3: Dar Zavain, Director

Holds 0 shares of No securities beneficially owned

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support